WASHINGTON, Nov. 17, 2016 /PRNewswire/ -- A campaign to encourage people with lung cancer and their physicians to "Don't Guess. Test." is being launched as part of November's Lung Cancer Awareness month activities. The campaign and website, www.dontguesstest.org, aim to educate and highlight the importance of comprehensive genomic testing in lung cancer. Lung cancer is the leading cause of death among both men and women, accounting for 1 out of 4 cancer deaths. The development of targeted therapies - medicines designed to address the underlying genomic drivers of cancer - has revolutionized the treatment of lung cancer; however there is an inherent need to match the right treatment to patients based on their specific genomic makeup. Launched by the Bonnie J. Addario Lung Cancer Foundation and Foundation Medicine, the "Don't Guess. Test." campaign provides patients and their physicians with information about the rapidly evolving genomic understanding of lung cancer, targeted therapy options and comprehensive genomic testing. The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient. "Each lung cancer is unique, like a fingerprint, and no two people have the same exact type," said Bonnie J. Addario, lung cancer survivor and founder of one of the largest lung cancer philanthropies. "There are modern, effective treatments available and important clinical trials for new targeted therapies, but making treatment decisions without knowing the specific genomics of your cancer is a little like playing darts while blindfolded. A comprehensive approach to genomic testing, or identifying targetable molecular markers, can ensure that patients and their doctors have the most information to make the best treatment decision. That's why we tell people, don't guess, test." About the Bonnie J. Addario Lung Cancer Foundation The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised nearly $30 million for lung cancer research and related programs. For more information about the ALCF please visit www.lungcancerfoundation.org or follow us on Facebook or Twitter.